Cerenome CNSY
NASDAQ CNSY
$1.60 -0.18 (-10.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cerenome (CNSY) Accumulated Expenses (2011 - 2012)

Updated

Cerenome (CNSY) recorded Accumulated Expenses of $9,000 in Q4 2012, down 81.3% from $48,000 a year earlier.

Analysis

Cerenome (CNSY) Accumulated Expenses (2011 - 2012) Analysis & Trends

  • Across earlier years, Accumulated Expenses came in at $48,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Cerenome 13.01 Mn -34.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 9,000.00
Dec 31, 2011 48,000.00
API Access

Cerenome Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CNSY&period=max&api_key=YOUR_API_KEY